Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Depreciation & Amortization (CF): 2012-2024

Historic Depreciation & Amortization (CF) for Theravance Biopharma (TBPH) over the last 13 years, with Dec 2024 value amounting to $1.7 million.

  • Theravance Biopharma's Depreciation & Amortization (CF) fell 5.59% to $405,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 1.85%. This contributed to the annual value of $1.7 million for FY2024, which is 14.54% down from last year.
  • Latest data reveals that Theravance Biopharma reported Depreciation & Amortization (CF) of $1.7 million as of FY2024, which was down 14.54% from $2.0 million recorded in FY2023.
  • Theravance Biopharma's 5-year Depreciation & Amortization (CF) high stood at $4.8 million for FY2021, and its period low was $1.7 million during FY2024.
  • In the last 3 years, Theravance Biopharma's Depreciation & Amortization (CF) had a median value of $2.0 million in 2023 and averaged $2.5 million.
  • As far as peak fluctuations go, Theravance Biopharma's Depreciation & Amortization (CF) grew by 2.02% in 2021, and later crashed by 46.15% in 2023.
  • Yearly analysis of 5 years shows Theravance Biopharma's Depreciation & Amortization (CF) stood at $4.7 million in 2020, then climbed by 2.02% to $4.8 million in 2021, then declined by 22.62% to $3.7 million in 2022, then plummeted by 46.15% to $2.0 million in 2023, then decreased by 14.54% to $1.7 million in 2024.